Flubromazepam

Flubromazepam

Systematic (IUPAC) name
7-Bromo-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one
Clinical data
Legal status	CA: Schedule IV DE: Anlage II (Prohibited)
Routes of administration	Oral
Pharmacokinetic data
Biological half-life	106 hours
Identifiers
CAS Number	2647-50-9 Y
PubChem	CID: 12947024
ChemSpider	10441497
UNII	GKX573279U Y
Chemical data
Formula	C15H10BrFN2O
Molecular mass	333.16 g/mol
SMILES BrC1=CC(C(C2=CC=CC=C2F)=NC3)=C(C=C1)NC3=O
InChI InChI=1S/C15H10BrFN2O/c16-9-5-6-13-11(7-9)15(18-8-14(20)19-13)10-3-1-2-4-12(10)17/h1-7H,8H2,(H,19,20) Key:ZRKDDZBVSZLOFS-UHFFFAOYSA-N

Flubromazepam is a benzodiazepine derivative which was first synthesized in 1960, but was never marketed and did not receive any further attention or study until late 2012 when it appeared on the grey market as a novel designer drug.

It is a structural analog of phenazepam in which the chlorine atom has been replaced by a fluorine atom.

An alternate isomer, 5-(2-bromophenyl)-7-fluoro-1,3-dihydro-2H-1,4-benzodiazepin-2-one, may have been sold under the same name.

Alternate isomer

See also

• 3-Hydroxyphenazepam
• Adinazolam
• Desmethyletizolam
• Desmethylflunitrazepam
• Diclazepam
• Etizolam
• Flubromazolam
• Imidazenil
• Meclonazepam
• Nifoxipam
• Phenazepam
• Pyrazolam